PureTech Health plc (LON:PRTC – Get Rating)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 247.27 ($2.97) and traded as low as GBX 204.50 ($2.46). PureTech Health shares last traded at GBX 208.50 ($2.51), with a volume of 116,326 shares changing hands.
PureTech Health Trading Down 1.4 %
The company has a 50 day moving average of GBX 247.27 and a 200 day moving average of GBX 248.50. The firm has a market cap of £581.01 million, a P/E ratio of -5,212.50 and a beta of 0.83. The company has a debt-to-equity ratio of 8.35, a quick ratio of 2.51 and a current ratio of 2.54.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Read More
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
